NCT00888407
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +13 more
- Locations
-
- UC Davis Cancer Center Sacramento, California, United States
Clinical trial condition
Blood-Borne Infections
Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.
8,283 public trials
441 recruiting studies
Blood-Borne Infections trial results
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
NCT00257621
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Fort Lauderdale, Florida, United States
NCT01053741
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Johns Hopkins University Drug Development Unit Baltimore, Maryland, United States
NCT00082394
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Oakland, California, United States
- GSK Investigational Site San Francisco, California, United States
Completed
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
NCT00968630
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
NCT00414050
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT01097655
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT02301507
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Thomas Street Health Center Houston, Texas, United States